Source: Forbes Author: Matthew Herper Martin Duffy, a Boston consultant and economist, thought he just had a sore throat. When it persisted for months, he went to the doctor and learned there was a tumor on his tonsils. Duffy, now 70, had none of the traditional risk factors for throat cancer. He doesn’t smoke, doesn’t drink and has run [...]
Continue reading...Thursday, July 8, 2010
Source: Bright Hub Author: Kira Jaines Can a kiss transmit HPV? Or oral sex? Studies conducted by researchers at Johns Hopkins University found that not only can human papilloma virus be transmitted orally, it can also increase the risk of oropharyngeal cancer. Can HPV Be Transmitted Orally? In a word, yes. Once thought to be uncommon, the oral transmission [...]
Continue reading...Sunday, June 27, 2010
Source: www.hemonctoday.com Author: Christen Cona In February, at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz., Maura Gillison, MD, PhD, professor and Jeg Coughlin Chair of Cancer Research at The Ohio State University in Columbus, presented data that showed that the proportion of all head and neck squamous cell cancers that were of the oropharynx [...]
Continue reading...Thursday, May 20, 2010
Source: The News and Observer Author: Martha Quillin May 19–RALEIGH — North Carolina could be among the first states to eliminate cervical cancer, according to a group of health care experts who launched an effort Tuesday with that goal. More than 100 clinicians, researchers, community activists and some cancer survivors attended the launch of the Cervical Cancer-Free Initiative [...]
Continue reading...Friday, May 14, 2010
Source: The Boston Channel Author: Staff Boston cancer specialists are trying to learn what’s behind an “epidemic” spike in oral cancer cases that they say is caused by the human papillomavirus, commonly known as HPV. “What you’re seeing here is a five-fold increase in the numbers that we would expect,” said Dr. Marshall R. Posner, of the Dana [...]
Continue reading...Sunday, April 11, 2010
Source: www.hemonctoday.com Author: Debbie Blamble, PharmD, BCOP HPVs are double-stranded DNA viruses that affect epithelial cells. More than 100 strains of HPV have been detected. Approximately 40 strains are known to infect genital mucosa, of which about 15 strains are known to cause cancer. HPV types 16 and 18 are the most common cancer-causing strains, leading to [...]
Continue reading...Thursday, February 11, 2010
Source: www.ctv.ca Author: staff Canadian women have a choice of two vaccines against HPV, the family of viruses that can cause cervical cancer, now that Health Canada has approved GlaxoSmithKline’s vaccine, Cervarix. The vaccine, which is expected to be available by the end of the month, will compete against Gardasil, a product of Merck Canada, which has been [...]
Continue reading...Wednesday, December 30, 2009
Source: www.cancernetwork.com Author: Fram Lowry Out with the old and in with the new is a commonly followed maxim in medicine given the rapid pace of developments in diagnosis and treatment. Human papillomavirus vaccines are relative newcomers to the cervical cancer armamentarium, but they cannot be relied on to do the job on their own; screening is [...]
Continue reading...Monday, December 7, 2009
Source: professional.cancerconsultants.com Author: staff Researchers affiliated with the GlaxoSmithKline Vaccine HPV-007 Study Group have reported that Cervarix® [human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine] has “high and sustained immunogenicity, and a favorable safety” profile for up to 6.4 years following administration. The details of this study appeared in an early online publication in the Lancet on December 3, 2009.[1] Cervarix [...]
Continue reading...Tuesday, November 10, 2009
Source: www.newswise.com Author: staff Breakthrough study reports complete and partial remissions following vaccination A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. According to a report published in the November 5 [...]
Continue reading...
Wednesday, July 21, 2010
0 Comments